Abstract
Ion exchange chromatography (IEC) poses stresses on proteins in both binding and elution steps. Proteins often bind to the column with high affinity, resulting in concentration of the protein upon binding. Elution often requires high salt concentration, leading to high protein concentration with high salt concentration. Although hydrophobic interaction chromatography (HIC) involves weak interaction, salting-out salts are used for binding. These conditions may cause protein aggregation. This short article describes an approach to reduce such aggregation in IEC and HIC. This was achieved by adding small amount of salt or arginine in the loading sample or elution solvent, resulting in elution of proteins with less aggregation or higher recovery.
Current Pharmaceutical Biotechnology
Title: Stress-Free Chromatography: IEC and HIC
Volume: 10 Issue: 4
Author(s): Tsutomu Arakawa, Yoshiko Kita and Daisuke Ejima
Affiliation:
Abstract: Ion exchange chromatography (IEC) poses stresses on proteins in both binding and elution steps. Proteins often bind to the column with high affinity, resulting in concentration of the protein upon binding. Elution often requires high salt concentration, leading to high protein concentration with high salt concentration. Although hydrophobic interaction chromatography (HIC) involves weak interaction, salting-out salts are used for binding. These conditions may cause protein aggregation. This short article describes an approach to reduce such aggregation in IEC and HIC. This was achieved by adding small amount of salt or arginine in the loading sample or elution solvent, resulting in elution of proteins with less aggregation or higher recovery.
Export Options
About this article
Cite this article as:
Arakawa Tsutomu, Kita Yoshiko and Ejima Daisuke, Stress-Free Chromatography: IEC and HIC, Current Pharmaceutical Biotechnology 2009; 10 (4) . https://dx.doi.org/10.2174/138920109788488879
DOI https://dx.doi.org/10.2174/138920109788488879 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Coronavirus Disease 2019: Virology and Drug Targets
Infectious Disorders - Drug Targets Candida parapsilosis Secreted Lipase as an Important Virulence Factor
Current Protein & Peptide Science IL-17 and its Receptor Complex as Therapeutic Targets in Arthritis
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Antiinflammatory Activity of Melatonin in Central Nervous System
Current Neuropharmacology rDNA Mediated Bioconjugates: Fusion Proteins and their Intended Use in Medicine
Current Topics in Medicinal Chemistry Treatment of High-Grade Pelvic-Type Serous Carcinomas (Ovary, Fallopian Tube and Peritoneum): Current Therapeutic Paradigms, Prospects, and Challenges
Current Cancer Therapy Reviews Molecular Modeling Approaches for the Prediction of Selected Pharmacokinetic Properties
Current Topics in Medicinal Chemistry Recent Patents on Novel P2X7 Receptor Antagonists Potentially Effective for Treatment of Inflammatory Diseases
Recent Patents on Biomarkers Uterine Wound Healing: A Complex Process Mediated by Proteins and Peptides
Current Protein & Peptide Science Pathogenesis of Chronic “Cor pulmonale” in COPD
Current Respiratory Medicine Reviews Natural COX-2 Inhibitors as Promising Anti-inflammatory Agents: An Update
Current Medicinal Chemistry Editorial [ The Wide Roles of Cytokines During Evolution Executive Editors: M. de Eguileor and E. Ottaviani ]
Current Pharmaceutical Design Telomerase Inhibitors as Anticancer Therapy
Current Medicinal Chemistry - Anti-Cancer Agents Overview on Plant Antimicrobial Peptides
Current Protein & Peptide Science Oncolytic Viruses: Programmable Tumour Hunters
Current Gene Therapy Selective Cyclooxygenase Inhibitors: Current Status
Current Drug Discovery Technologies Management of Peyronie's Disease after Collagenase (Xiaflex:<sup>®</sup>)
Current Drug Targets Nucleoside Inhibitors of Coronaviruses
Current Medicinal Chemistry Pain and Obesity in the Older Adult
Current Pharmaceutical Design Protein Kinase C ζ Drives Sphingomyelin Metabolism in the Nucleus During Cell Proliferation
Current Chemical Biology